Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06337617
Status:
COMPLETED
Last Update Posted:
2024-03-29
First Post:
2024-03-22
Brief Title:
A Multi-center Retrospective Study With Secondary Use of Data of Tafinlar Dabrafenib Plus Mekinist Trametinib in Chinese Patients With BRAF V600 Mutation Positive Melanoma
Sponsor:
Organization:
Novartis